Literature DB >> 8663474

The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors.

L M Regan1, D J Stearns-Kurosawa, S Kurosawa, J Mollica, K Fukudome, C T Esmon.   

Abstract

A soluble form of the endothelial cell protein C receptor (EPCR) was analyzed for the ability to modulate the functional properties of protein C and activated protein C (APC). In a plasma clotting system initiated with factor Xa, EPCR blocked the anticoagulant activity of APC in a dose-dependent fashion. EPCR had no influence on clotting in the absence of APC. Consistent with the plasma results, EPCR slowed the proteolytic inactivation of factor Va by slowing both of the key proteolytic cleavages in the heavy chain of factor Va. EPCR did not prevent protein C activation by the soluble thrombin-thrombomodulin complex, did not alter the inactivation of APC by alpha1-antitrypsin or protein C inhibitor, and did not influence the kinetics of peptide paranitroanilide substrate cleavage significantly. We conclude that EPCR binds to an exosite on APC that selectively modulates the enzyme specificity in a manner reminiscent of the influence of thrombomodulin on thrombin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663474     DOI: 10.1074/jbc.271.29.17499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 2.  Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling.

Authors:  Shiri Gur-Cohen; Orit Kollet; Claudine Graf; Charles T Esmon; Wolfram Ruf; Tsvee Lapidot
Journal:  Ann N Y Acad Sci       Date:  2016-03-01       Impact factor: 5.691

3.  Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease-activated receptor-1 and endothelial cell protein C receptor.

Authors:  Laurent O Mosnier; John H Griffin
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

4.  Identification of functional endothelial protein C receptor in human plasma.

Authors:  S Kurosawa; D J Stearns-Kurosawa; N Hidari; C T Esmon
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

Review 5.  Thrombin generation in hemorrhage control and vascular occlusion.

Authors:  Kenneth G Mann
Journal:  Circulation       Date:  2011-07-12       Impact factor: 29.690

6.  Soluble endothelial protein C receptor levels in healthy population.

Authors:  Filiz Simsek Orhon; Huseyin Ergun; Yonca Egin; Betul Ulukol; Sevgi Baskan; Nejat Akar
Journal:  J Thromb Thrombolysis       Date:  2009-03-19       Impact factor: 2.300

7.  The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex.

Authors:  D J Stearns-Kurosawa; S Kurosawa; J S Mollica; G L Ferrell; C T Esmon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant.

Authors:  Jens E V Petersen; Eveline A M Bouwens; Ibai Tamayo; Louise Turner; Christian W Wang; Monique Stins; Thor G Theander; José Hermida; Laurent O Mosnier; Thomas Lavstsen
Journal:  Thromb Haemost       Date:  2015-07-09       Impact factor: 5.249

Review 9.  Factor VIIa binding to endothelial cell protein C receptor.

Authors:  L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Thromb Res       Date:  2008       Impact factor: 3.944

10.  Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma.

Authors:  Beatrice Saposnik; Elodie Lesteven; Anna Lokajczyk; Charles T Esmon; Martine Aiach; Sophie Gandrille
Journal:  Blood       Date:  2007-12-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.